Many studies have demonstrated that GPER mediates biological effects in various malignant tumors, including reproductive organs (such as endometrial (18) and ovarian cancers (19)) and other hormonally responsive organs (such as lung (20) and prostate cancers (21)). This evidence concerns the gene GPER1 and cancer.